Ora, Inc.
Andover, Massachusetts, 01810, United States
NCT Number: NCT01675609
The purpose of this study is to evaluate the safety and efficacy of brimonidine tartrate 0.025% ophthalmic solution used four times daily in a population of adult and geriatric subjects
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Phase 2
Andover, Massachusetts, 01810, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 drop in each eye daily for up to 35 days
1 drop in each eye for up to 35 days
Time frame: at specified timepoints for up to 180 minutes
redness evaluated by investigator prior to study medication instillation and redness evaluated by the subject as captured in dosing diary
Time frame: up to 5 minutes post study medication instillation
evaluated prior to study medication instillation and at 5 minutes post instillation
Eye Therapies, LLC
Industry
A Single-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06803654
Ocular Redness
Glendale, California, United States
View Trial DetailsNCT06538662
Eye Irritation, Ocular Redness
Azusa, California, United States
View Trial DetailsNCT06444529
Ocular Redness
Glendale, California, United States
View Trial DetailsNCT05360784
Ocular Redness
Colorado Springs, Colorado, United States
View Trial Details